Literature DB >> 24121514

Elastin degradation by cathepsin V requires two exosites.

Xin Du1, Nelson L H Chen, Andre Wong, Charles S Craik, Dieter Brömme.   

Abstract

Cathepsin V is a highly effective elastase and has been implicated in physiological and pathological extracellular matrix degradation. However, its mechanism of action remains elusive. Whereas human cathepsin V exhibits a potent elastolytic activity, the structurally homologous cathepsin L, which shares a 78% amino acid sequence, has only a minimal proteolytic activity toward insoluble elastin. This suggests that there are distinct structural domains that play an important role in elastinolysis. In this study, a total of 11 chimeras of cathepsins V and L were generated to identify elastin-binding domains in cathepsin V. Evaluation of these chimeras revealed two exosites contributing to the elastolytic activity of cathepsin V that are distant from the active cleft of the protease and are located in surface loop regions. Replacement of exosite 1 or 2 with analogous residues from cathepsin L led to a 75 and 43% loss in the elastolytic activity, respectively. Replacement of both exosites yielded a non-elastase variant similar to that of cathepsin L. Identification of these exosites may contribute to the design of inhibitors that will only affect the elastolytic activity of cysteine cathepsins without interfering with other physiological protease functions.

Entities:  

Keywords:  Cathepsin V; Cysteine Protease; Elastase; Elastin; Exosite; Extracellular Matrix Proteins; Protein Degradation; Site-directed Mutagenesis; Substrate Specificity

Mesh:

Substances:

Year:  2013        PMID: 24121514      PMCID: PMC3843099          DOI: 10.1074/jbc.M113.510008

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design.

Authors:  Fabien Lecaille; Jadwiga Kaleta; Dieter Brömme
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  Crystal structure of human cathepsin V.

Authors:  J R Somoza; H Zhan; K K Bowman; L Yu; K D Mortara; J T Palmer; J M Clark; M E McGrath
Journal:  Biochemistry       Date:  2000-10-17       Impact factor: 3.162

Review 3.  Aging: overview.

Authors:  D Harman
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

4.  Remote exosites of the catalytic domain of matrix metalloproteinase-12 enhance elastin degradation.

Authors:  Yan G Fulcher; Steven R Van Doren
Journal:  Biochemistry       Date:  2011-10-11       Impact factor: 3.162

5.  Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages.

Authors:  Yoshiyuki Yasuda; Zhenqiang Li; Doron Greenbaum; Matthew Bogyo; Ekkehard Weber; Dieter Brömme
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

Review 6.  Lysosomal cysteine proteases (cathepsins): promising drug targets.

Authors:  Dusan Turk; Gregor Guncar
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-01-23

Review 7.  Lysosomal cysteine proteases in atherosclerosis.

Authors:  Jian Liu; Galina K Sukhova; Jiu-Song Sun; Wei-Hua Xu; Peter Libby; Guo-Ping Shi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-03       Impact factor: 8.311

8.  Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

Authors:  Eva Tolosa; Weijie Li; Yoshiyuki Yasuda; Wolfgang Wienhold; Lisa K Denzin; Alfred Lautwein; Christoph Driessen; Petra Schnorrer; Ekkehard Weber; Stefan Stevanovic; Raffael Kurek; Arthur Melms; Dieter Bromme
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L.

Authors:  Luciano Puzer; Simone S Cotrin; Marcio F M Alves; Tobore Egborge; Mariana S Araújo; Maria Aparecida Juliano; Luiz Juliano; Dieter Brömme; Adriana K Carmona
Journal:  Arch Biochem Biophys       Date:  2004-10-15       Impact factor: 4.013

Review 10.  The cell-elastin-elastase(s) interacting triade directs elastolysis.

Authors:  William Hornebeck; Herve Emonard
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01
View more
  15 in total

1.  l-Homocysteine-induced cathepsin V mediates the vascular endothelial inflammation in hyperhomocysteinaemia.

Authors:  Yi-Ping Leng; Ye-Shuo Ma; Xiao-Gang Li; Rui-Fang Chen; Ping-Yu Zeng; Xiao-Hui Li; Cheng-Feng Qiu; Ya-Pei Li; Zhen Zhang; Alex F Chen
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

2.  Cathepsin L induced PC-12 cell apoptosis via activation of B-Myb and regulation of cell cycle proteins.

Authors:  Xiao Shen; Yi-Fan Zhao; Shu-Qing Xu; Long Wang; Hui-Min Cao; Ying Cao; Ying Zhu; Yan Wang; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2019-08-23       Impact factor: 6.150

3.  Tri-arginine exosite patch of caspase-6 recruits substrates for hydrolysis.

Authors:  Derek J MacPherson; Caitlyn L Mills; Mary Jo Ondrechen; Jeanne A Hardy
Journal:  J Biol Chem       Date:  2018-11-12       Impact factor: 5.157

4.  Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.

Authors:  Jingjing Cai; Hua Zhong; Jinze Wu; Rui-Fang Chen; Huan Yang; Yousef Al-Abed; Ying Li; Xiaohui Li; Weihong Jiang; Marcelo Freitas Montenegro; Hong Yuan; Timothy Billiar; Alex F Chen
Journal:  Mol Med       Date:  2016-03-20       Impact factor: 6.354

5.  Extracellular matrix turnover in coronary artery ectasia patients.

Authors:  Ruifeng Liu; Lianfeng Chen; Wei Wu; Houzao Chen; Shuyang Zhang
Journal:  Heart Vessels       Date:  2015-01-10       Impact factor: 2.037

6.  A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K.

Authors:  Preety Panwar; Kent Søe; Rafael Vc Guido; Renata V C Bueno; Jean-Marie Delaisse; Dieter Brömme
Journal:  Br J Pharmacol       Date:  2015-12-16       Impact factor: 8.739

7.  Molecular modeling for potential cathepsin L inhibitor identification as new anti-photoaging agents from tropical medicinal plants.

Authors:  Sophi Damayanti; Nabilla Rizkia Fabelle; Wipawadee Yooin; Muhamad Insanu; Supat Jiranusornkul; Pathomwat Wongrattanakamon
Journal:  J Bioenerg Biomembr       Date:  2021-04-05       Impact factor: 2.945

8.  Dual-Mechanism Quenched Fluorogenic Probe Provides Selective and Rapid Detection of Cathepsin L Activity*.

Authors:  Kelton A Schleyer; Ben Fetrow; Peter Zannes Fatland; Jun Liu; Maya Chaaban; Biwu Ma; Lina Cui
Journal:  ChemMedChem       Date:  2021-01-15       Impact factor: 3.466

9.  A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K.

Authors:  Simon Law; Preety Panwar; Jody Li; Adeleke H Aguda; Andrew Jamroz; Rafael V C Guido; Dieter Brömme
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

10.  Neutrophil serine proteases and their endogenous inhibitors in coronary artery ectasia patients.

Authors:  Ruifeng Liu; Lianfeng Chen; Wei Wu; Houzao Chen; Shuyang Zhang
Journal:  Anatol J Cardiol       Date:  2016-01       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.